Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Missing values were imputed by a pattern mixture model using multiple imputation (MI)
Typically, we set the starting dose at 0.25 mg once a week
The most successful candidates are committed to long-term change and willing to integrate lifestyle improvements such as healthy eating and regular activity
Conclusion The Phase I/II trial establishes MET-097i as a promising ultra-long-acting GLP-1 receptor agonist with the potential for monthly dosing and minimal titration
(2022) 46:e16901
Always consult a licensed healthcare provider before starting, changing, or stopping any medical treatment
US$ 29.81
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 23.58
US$ 23.66
US$ 24.83
US$ 26.70
